ABMD: ABIOMED, Inc. Twitter on Stock

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, May 2, 12:57 PM Abiomed (ABMD +6.7%) moves up after Q1 revenues come in well ahead of expectations, lifted by a 22% jump in revenue from its Impella temporary heart product to $36.5M from $29.9M. An additional 30 hospitals purchased the Impella 2.5 during the quarter, bringing the total to 748 customer sites. An additional 55 hospitals purchased the Impella CP, bringing the total number of Impella CP sites to 106. Gross margin slipped to 79.8% from 81.8% Y/Y, while operating margin was 9.5%, compared to 7.9% over the same period. Comment! [Healthcare, Earnings, On the Move]
Thursday, May 2, 7:20 AM Abiomed (ABMD): FQ4 EPS of $0.09. Revenue of $43.7M (+17% Y/Y) beats by $1.75M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, May 2, 12:05 AM Notable earnings before Thursday’s open: ABMD, ACOR, ACT, AEE, ANR, ANSS, ARG, ARQL, ATK, AYR, BDBD, BDX, BEAM, BGCP, BZH, CAH, CEVA, CHD, CI, CME, CNP, CPN, CTRX, DIN, DNR, EL, ELNK, FIG, FLY, FNP, FWLT, GEL, GG, GIL, GM, GNRC, GOLD, HAR, HK, HSH, INCY, INGR, IP, IRDM, IT, ITT, K, LF, LQDT, LXP, MDC, MFC, MGI, MGM, MMC, MMP, MWW, NIHD, NNN, NUS, OCN, OGE, OXF, OZM, PCG, PPL, PWR, PXP, RGLD, RNO, SBH, SFY, SHPG, SNI, SPR, SRE, STRA, TEVA, VMC, VRX, WNR, WPX, WWE, XEL Comment! [Earnings]
Wednesday, May 1, 5:30 PM Notable earnings before Thursday’s open: ABMD, ACOR, ACT, AEE, ANR, ANSS, ARG, ARQL, ATK, AYR, BDBD, BDX, BEAM, BGCP, BZH, CAH, CEVA, CHD, CI, CME, CNP, CPN, CTRX, DIN, DNR, EL, ELNK, FIG, FLY, FNP, FWLT, GEL, GG, GIL, GM, GNRC, GOLD, HAR, HK, HSH, INCY, INGR, IP, IRDM, IT, ITT, K, LF, LQDT, LXP, MDC, MFC, MGI, MGM, MMC, MMP, MWW, NIHD, NNN, NUS, OCN, OGE, OXF, OZM, PCG, PPL, PWR, PXP, RGLD, RNO, SBH, SFY, SHPG, SNI, SPR, SRE, STRA, TEVA, VMC, VRX, WNR, WPX, WWE, XEL Comment! [Earnings]
Wednesday, April 17, 9:12 AM Premarket gainers: VRML +29%. ACUR +26%. OCZ +18%. CUR +9%. ALKS +9%. ABMD +9%. ASML +6%.
Losers: EOPN -29%. INWK -25%. CXW -15%. MHR -12%. ZGNX -11%. TXT -9%. CRUS -7%. VRNG -6%. 1 Comment [On the Move]
Wednesday, April 17, 8:56 AM Abiomed (ABMD) soars 8.7% premarket after announcing preliminary Q4 revenue of $43.7M, representing 17% and 14% Y/Y and sequential top line growth respectively. For FY2013 the company says revenue grew 25% to $158.1M. Analysts were expecting $41.5M for Q4 and $156.04M for the full year. This marks the third straight year ABMD has topped its full year revenue guidance. Comment! [Healthcare, On the Move]
Tuesday, April 9, 1:54 PM Shares of Abiomed (ABMD -3.6%) suffer after Piper Jaffray downgrades the stock to Neutral with a reiterated price target of $18, citing potential drag from FDA premarket approval requirements. On the bright side, "a growing product pipeline [and] the potential for movement into new markets such as Japan … should put a floor under the shares," according to analyst Brooks West. Comment! [Healthcare, On the Move]
Wednesday, February 6, 5:43 PM After-hours top gainers, as of 5:15 p.m.: DV +13%. ZUMZ +8%. WNC +7%. ABMD +6%. LF +6%.
After-hours top losers: AKAM -16%. KFRC -14%. ZOLT -11%. IRBT -9%. PSMI -9%. Comment! [On the Move]
Wednesday, February 6, 3:29 PM Abiomed (ABMD -6.1%) takes a hit after the medical device company missed on its Q4 EPS result earlier this morning, and reaffirmed an FY13 guidance that trails Street expectations. It now forecasts revenue of $155M to $157M, lagging consensus by around $1M. Comment! [Healthcare, Earnings, On the Move]
Wednesday, February 6, 7:03 AM Abiomed (ABMD): FQ3 Gaap EPS of $0.07 misses by $0.05. Revenue of $38.3M (+19% Y/Y) beats by $0.26M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Wednesday, February 6, 12:05 AM Notable earnings before Wednesday’s open: ABMD, AINV, CMI, CMP, CVH, CVS, ELN, GAS, ICE, IVR, MPEL, MRO, MT, NUS, PLD, RL, TWX, USG, VICL, VMED Comment! [Earnings]
Tuesday, February 5, 5:30 PM Notable earnings before Wednesday’s open: ABMD, AINV, CMI, CMP, CVH, CVS, ELN, GAS, ICE, IVR, MPEL, MRO, MT, NUS, PLD, RL, TWX, USG, VICL, VMED Comment! [Earnings]
Monday, December 17, 2012, 5:39 PM S&P announces some changes to its indices: United Natural Foods (UNFI) will replace Amerigroup (AGP) in the S&P MidCap 400, and Ixia (XXIA) will replace United Natural Foods in the S&P SmallCap 600. Wellpoint (WLP) is acquiring AGP in a deal expected to be completed soon. Abiomed (ABMD) is also to be added to the S&P 600, replacing Cascade (CASC) as of the December 21st close of trading. Toyota Industries is acquiring Cascade, which also should be completed soon. Comment! [Healthcare, Consumer, Financials]
Monday, December 10, 2012, 3:40 PM A group of Democratic Senators have signed a letter urging for a delay in implementing a tax on the medical device industry that is scheduled to go into effect January 1, saying the industry has received little guidance about how to comply with the tax, and is causing significant uncertainty and confusion. The Senators are requesting that a delay be included in the fiscal cliff bill Congress is currently negotiating. 2 Comments
Friday, December 7, 2012, 11:32 AM Abiomed (ABMD -6.4%) trades down today coming off a 2-day trading halt, touching a 52-week low of $11.80 after the company announced that the FDA Circulatory System Devices Panel voted to retain Class III status for the temporary ventricular support devices within the non-roller type cardiopulmonary bypass blood pumps category - which includes ABMD's Impella - rather than the lower-risk Class II category it had hoped for. Comment! [Healthcare, On the Move]
Friday, December 7, 2012, 9:10 AM Premarket gainers: GALE +9%. ACRX +7%.
Losers: AMRN -19%. ABMD -7%. QRE -5%. Comment! [On the Move]

ABMD ABIOMED, Inc.

ABMD

ABIOMED, Inc.